159 related articles for article (PubMed ID: 9309332)
1. Prognostic significance of occult lymph node metastases in node-negative breast cancer.
Clare SE; Sener SF; Wilkens W; Goldschmidt R; Merkel D; Winchester DJ
Ann Surg Oncol; 1997 Sep; 4(6):447-51. PubMed ID: 9309332
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
[TBL] [Abstract][Full Text] [Related]
4. Occult axillary lymph node metastases in "node-negative" breast carcinoma.
Nasser IA; Lee AK; Bosari S; Saganich R; Heatley G; Silverman ML
Hum Pathol; 1993 Sep; 24(9):950-7. PubMed ID: 7504652
[TBL] [Abstract][Full Text] [Related]
5. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
6. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.
Cote RJ; Peterson HF; Chaiwun B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Gusterson B; Neville AM
Lancet; 1999 Sep; 354(9182):896-900. PubMed ID: 10489948
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
[TBL] [Abstract][Full Text] [Related]
8. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
[TBL] [Abstract][Full Text] [Related]
9. Occult lymph node metastases in early stage vulvar carcinoma patients.
Knopp S; Holm R; Tropé C; Nesland JM
Gynecol Oncol; 2005 Nov; 99(2):383-7. PubMed ID: 16051338
[TBL] [Abstract][Full Text] [Related]
10. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
[TBL] [Abstract][Full Text] [Related]
11. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
12. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
[TBL] [Abstract][Full Text] [Related]
14. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer.
Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Matsuda K; Hatakeyama K
J Gastroenterol; 1997 Dec; 32(6):758-64. PubMed ID: 9430013
[TBL] [Abstract][Full Text] [Related]
15. Lymph node micrometastases do not predict relapse in stage II colon cancer.
Tschmelitsch J; Klimstra DS; Cohen AM
Ann Surg Oncol; 2000 Sep; 7(8):601-8. PubMed ID: 11005559
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
17. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
[TBL] [Abstract][Full Text] [Related]
18. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma.
Chen ZL; Perez S; Holmes EC; Wang HJ; Coulson WF; Wen DR; Cochran AJ
J Natl Cancer Inst; 1993 Mar; 85(6):493-8. PubMed ID: 7680382
[TBL] [Abstract][Full Text] [Related]
19. Effect of occult metastases on survival in node-negative breast cancer.
Weaver DL; Ashikaga T; Krag DN; Skelly JM; Anderson SJ; Harlow SP; Julian TB; Mamounas EP; Wolmark N
N Engl J Med; 2011 Feb; 364(5):412-21. PubMed ID: 21247310
[TBL] [Abstract][Full Text] [Related]
20. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging.
Turner RR; Ollila DW; Stern S; Giuliano AE
Am J Surg Pathol; 1999 Mar; 23(3):263-7. PubMed ID: 10078915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
